Keyphrases
A1 Receptor
100%
National Cohort Study
100%
Metformin
100%
Receptor Agonist
100%
Glucagon-like
100%
Drug-naïve Patients
100%
Confidence Interval
60%
Risk Ratio
40%
Pre-diabetes (pre-DM)
40%
Glucose-lowering Drugs
30%
Diabetes Risk
30%
Diabetes
20%
Non-adherence
20%
Nationwide Registers
10%
Multiple Linear Regression
10%
Risk Reduction
10%
Treatment Initiation
10%
Multinomial Logistic Regression
10%
Patients with Diabetes
10%
Add-on Therapy
10%
Glycated Hemoglobin
10%
Glycated Hemoglobin A1c
10%
HbA1c Reduction
10%
Therapy Adherence
10%
Therapeutic Change
10%
Biomarker Changes
10%
One-year Risk
10%
Medicine and Dentistry
Cohort Analysis
100%
Glycon
100%
Glucagon-Like Peptide-1 Agonist
100%
Impaired Glucose Tolerance
50%
Diabetes
30%
Drug Therapy
20%
Biological Marker
20%
Hemoglobin A1c
20%
Glycated Hemoglobin
20%
Multiple Linear Regression Analysis
10%
Patient with Diabetes
10%
Patient Compliance
10%
Multivariate Logistic Regression Analysis
10%
Add on Therapy
10%